Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Burden of ACC Through the Eyes of Patients

NCT04706845 is registered in ClinicalTrials.gov with Ayala Pharmaceuticals, Inc, as lead sponsor.

NCT NCT04706845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04706845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Burden of ACC Through the Eyes of Patients
Lead sponsor
Ayala Pharmaceuticals, Inc,
Phase
Observational
Overall status
Completed
Start date
January 11, 2021
Completion date
August 16, 2023
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenoid cystic carcinoma